Viewing nowCombinationDoublelow Tablet 80/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.

MFDS item code 201606204 · Approved 2016.10.21 · Insurance code 641705230
Treatment of essential hypertension not controlled with monotherapy
This medication is suitable for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or telmisartan. In other words, it assists in effectively lowering blood pressure when it is not well controlled with a single medication. This, in turn, contributes to the prevention of cardiovascular diseases and improves blood pressure management.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine); however, direct conversion to this drug may be considered if blood pressure is not controlled with the individual components, as follows: - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients 75 years of age or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Use of this drug is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be avoided by women who are pregnant or may become pregnant. It should not be used by patients with allergies to the active ingredients or similar components, severely impaired liver, heart, or kidney function, pregnant women, nursing mothers, and patients with certain heart diseases. Patients with primary aldosteronism, certain heart valve diseases, reduced liver function, gastrointestinal diseases, or problems with renal vasculature should use this medication with caution. Common side effects may include dizziness or peripheral edema, and while serious side effects can occur rarely, any abnormal symptoms should prompt immediate consultation with a physician. This medication should not be initiated during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible. It lowers blood pressure, so patients at risk of hypotension should consult their doctor before taking it. Potassium levels in the blood may increase, so particularly patients with reduced kidney function or heart failure should have their potassium levels monitored regularly. Patients with reduced kidney function should monitor their kidney function and potassium levels periodically while taking this medication, and those with heart disease should observe symptoms carefully. This medication may interact with certain other drugs, so if any other medications are being taken, the physician or pharmacist must be informed. Elderly patients may respond more sensitively to this medication, thus requiring dosage adjustments and careful monitoring. In case of overdose, symptoms such as hypotension, dizziness, and arrhythmias may appear, so immediate medical attention is necessary. This medication has not been established as safe and effective for children and is not recommended for use in this population. Keep the medication out of reach of children, take it immediately after opening, and avoid transferring it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container protected from light and kept at a temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the drug's effectiveness and prevent deterioration.
White or off-white rectangular tablet
30 tablets (10 tablets/AluAlu * 3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.